Heading,Source,Date,Symbol
"Sun Pharma Q2 Preview: Favourable seasonality, robust specialty sales to keep earnings in the pink of...",Moneycontrol,24 Oct 2024,SUNPHARMA
"Sun Pharma Q2 Preview: Profit may rise by 19%, R&D spends to impact margins",Business Standard,25 Oct 2024,SUNPHARMA
